Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tiotropium (18mcg) Rotacaps
Therapeutic Category
Pulmonary, Respiratory, Asthma
Dosage Form
Rotacapsules
Packaging Type
in a bottle with carton
Packaging
30 Capsules
Price
₹366.24/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tioprime dry powder inhaler capsules is a specialized inhalation medication containing Tiotropium (18 mcg) designed for the long-term management of chronic obstructive pulmonary disease (COPD) and asthma. As a long-acting anticholinergic bronchodilator, Tiotropium works by inhibiting the action of acetylcholine on muscarinic receptors in the airways, leading to relaxation of the bronchial muscles and improved airflow. This mechanism helps to alleviate symptoms such as wheezing, shortness of breath, and chest tightness, allowing patients to breathe more easily and engage in daily activities with greater comfort.
The unique Rotacapsules delivery system ensures precise dosing and effective delivery of the medication directly to the lungs. Tropiturn is typically administered once daily, providing sustained bronchodilation over a 24-hour period. This convenient dosing schedule enhances patient adherence and helps maintain consistent control of respiratory symptoms.
Common side effects may include dry mouth, constipation, headache, and throat irritation. Some patients may experience urinary retention or increased heart rate. It is essential to monitor for any unusual symptoms during treatment.
Tropiturn is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma in adults.
Tropiturn should be used only as prescribed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms do not improve or worsen.
Store Tropiturn in a cool, dry place, away from direct sunlight and moisture. Ensure it is kept out of reach of children.
Composition : Budesonide (0.5mg) Respule
Composition : Budesonide (100mcg) Inhaler
Composition : Budesonide (200mcg) Inhaler
Composition : Budesonide (400mcg) + Formoterol (6mcg) Rota Caps
Composition : Budesonide (0.5mg) + Formoterol (20mcg) Respule
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
Composition : Levosalbutamol (1.25mg) + Budesonide (0.5mg) Respule
Composition : Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg) Rota Capsule
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tiotropium Rotacaps have strong demand in the respiratory and pulmonology segment, making them a stable and high-value product for pharma distributors, wholesalers, and franchise partners. It is widely prescribed for the maintenance treatment of COPD (Chronic Obstructive Pulmonary Disease), ensuring consistent long-term prescription-based demand.
Medical distributors and agencies benefit from the continuous and chronic-care driven demand in respiratory therapy. Tiotropium 18 mcg provides long-acting bronchodilation Helps in improving airflow and reducing breathlessness in COPD patients Commonly prescribed for maintenance therapy in COPD and chronic bronchitis Widely recommended by pulmonologists and respiratory physicians Strong demand in hospital prescriptions and long-term outpatient care Rotacap format ensures easy inhalation and good patient compliance This makes it a consistent and reliable product in the respiratory segment.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tiotropium 18 mcg Rotacaps with monopoly rights, promotional support, quality manufacturing standards, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and franchise partners benefit from long-term COPD treatment demand, repeat monthly prescriptions, strong hospital and pulmonology clinic usage, and stable turnover in the chronic respiratory care segment.
Interested distributors, stockists, and pharma franchise partners can contact Cafoli LifeCare Pvt Ltd to discuss monopoly territory rights, pricing structure, marketing support, and complete respiratory product portfolio access to build a strong presence in the pulmonology and chronic care market.